Q4 2024 US Physical Therapy Inc Earnings Call Transcript

Feb 27, 2025 / 03:30 PM GMT

Release Date Price: $82.42 (-6.04%)

Transcript 10-K

Key Points

Positve

US Physical Therapy Inc (USPH) achieved a record high in average visits per day at 31.7, indicating strong demand and operational efficiency.
The company reported a 13% year-over-year increase in total patient volume, showcasing robust growth in service utilization.
USPH completed seven acquisitions in 2024, expanding its presence into new states like Colorado and New York, which are performing well.
The injury prevention business saw a revenue growth of over 32% in the fourth quarter, contributing significantly to the company's overall performance.
USPH's balance sheet remains strong with a low debt level and a revolving credit facility, positioning the company well for future acquisitions and growth.

Negative

The company faces challenges in controlling costs per visit due to a competitive hiring environment for therapists, impacting profitability.
USPH absorbed a 1.8% Medicare rate reduction in 2024, and a further 2.9% reduction is expected in 2025, posing a revenue headwind.
Operating costs increased by 16.6% in the fourth quarter, partly due to acquisitions, which pressured margins.
The integration of Metro PT, acquired in November, resulted in a lower average rate, affecting overall revenue per visit.
The company's PT margin decreased from 19.5% in the fourth quarter of 2023 to 17.9% in the same period of 2024, indicating margin compression.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

USPH.N - US Physical Therapy Inc
Q4 2024 US Physical Therapy Inc Earnings Call
Feb 27, 2025 / 03:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
That you please continue to stand by.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
.

.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
Please stand by. Your program is about to begin.

Good day and thank you for standing by. Welcome to the US Physical Therapy 4th quarter 2024 and full year earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.